Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib. [electronic resource]
Producer: 20071018Description: 213-21 p. digitalISSN:- 0169-5002
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- blood
- CA-125 Antigen -- blood
- CA-19-9 Antigen -- blood
- Carcinoembryonic Antigen -- blood
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cohort Studies
- Female
- Gefitinib
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Predictive Value of Tests
- Quinazolines -- therapeutic use
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.